Lilly to Buy ImClone for $6.5 Billion
- Loading Comments...
Updated from 9:50 a.m. EDT
ImClone Systems (IMCL Quote) has agreed to be acquired by Eli Lilly (LLY Quote) for about $6.5 billion.
The agreement follows ImClone's rejection of a sweetened takeover offer from Bristol-Myers Squibb (BMY Quote). Bristol-Myers last week announced its intent to go hostile with its bid for ImClone, raising its offer to $62 a share and going directly to shareholders.
The Eli Lilly agreement, which values ImClone at $70 a share, has been approved by the boards of both ImClone and Eli Lilly. Shares of ImClone, which makes the cancer drug Erbitux, were rising 2.6% to $66.67 in recent trading. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |


Connect with TheStreet